Suppr超能文献

在接受心脏移植前从心脏移植等待名单上移除的患者的生存率。

Survival in patients removed from the heart transplant waiting list before receiving a transplant.

作者信息

VanderPluym Christina, Graham Dionne A, Almond Christopher S, Blume Elizabeth D, Milliren Carly E, Singh Tajinder P

机构信息

Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts.

Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts.

出版信息

J Heart Lung Transplant. 2014 Mar;33(3):261-9. doi: 10.1016/j.healun.2013.12.010. Epub 2013 Dec 17.

Abstract

BACKGROUND

Little is known about the outcomes in patients who are removed from the heart transplant (HT) waiting list before receiving a transplant. We sought to analyze outcomes in such patients in the United States (U.S.) in the current era.

METHODS

All patients aged ≥ 18 years old listed for a primary HT in the U.S. between July 2004 and September 2010 were identified. Outcomes in those removed from the list by March 2011 (survival, relisting, HT) were examined using time-to-event analyses.

RESULTS

Of 15,061 patients listed for primary HT, 10,168 (68%) received a HT, 1,393 (9%) died on the waiting list, and 1,871(12%) were removed before receiving HT. Of patients removed from the list, 560 (30%) were removed due to clinical improvement, 692 (37%) due to deterioration, and 619 (33%) due to other reasons. After removal, 30-day and 1-year survival were 99.6% and 94%, respectively, in patients removed due to improvement and 44% and 26%, respectively, in patients removed due to deterioration. Multivariable predictors of death after removal were removal due to clinical deterioration, hypertrophic or restrictive cardiomyopathy, United Network of Organ Sharing status 1A/1B at listing, and renal dysfunction. Only 27 patients (4.8%) among those removed due to improvement, 21 (3.0%) removed due to deterioration, and 46 (7.4%) removed due to other reasons were relisted.

CONCLUSIONS

One in 8 patients listed for HT in the U.S. are removed from the waiting list before receiving HT. The indication for removal (clinical deterioration vs improvement) is the strongest independent predictor of survival after removal from the list.

摘要

背景

对于在接受心脏移植(HT)前从等待名单上移除的患者的预后情况,人们了解甚少。我们试图分析当前美国这类患者的预后情况。

方法

确定2004年7月至2010年9月期间在美国登记进行初次HT的所有年龄≥18岁的患者。使用事件发生时间分析方法检查截至2011年3月从名单上移除的患者的预后情况(生存、重新登记、HT)。

结果

在15061名登记进行初次HT的患者中,10168名(68%)接受了HT,1393名(9%)在等待名单上死亡,1871名(12%)在接受HT前被移除。在从名单上移除的患者中,560名(30%)因临床改善而被移除,692名(37%)因病情恶化而被移除,619名(33%)因其他原因被移除。移除后,因改善而被移除的患者30天和1年生存率分别为99.6%和94%,因恶化而被移除的患者分别为44%和26%。移除后死亡的多变量预测因素包括因临床恶化而移除、肥厚型或限制型心肌病、登记时器官共享联合网络状态为1A/1B以及肾功能不全。因改善而被移除的患者中只有27名(4.8%)、因恶化而被移除的患者中有21名(3.0%)以及因其他原因被移除的患者中有46名(7.4%)重新登记。

结论

在美国,每8名登记进行HT的患者中就有1名在接受HT前从等待名单上被移除。移除的指征(临床恶化与改善)是从名单上移除后生存的最强独立预测因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验